[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Pages 23424-23425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07997]



Centers for Disease Control and Prevention

Solicitation of Nominations for Appointment to the CDC/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.


SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), is seeking 
nominations for membership on the CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment (CHAC). CHAC consists 
of 18 experts in fields associated with public health, epidemiology, 
laboratory practice, immunology, infectious diseases, substance use 
disorder, behavioral science, health education, healthcare delivery, 
state health programs, clinical care, preventive health, medical 
education, health services and clinical research, health equity, and 
healthcare financing, who are selected by the Secretary, HHS.

DATES: Nominations for membership on CHAC must be received no later 
than October 1, 2023. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected] 
with the subject line ``CHAC 2024 Nomination.''

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, Office of Policy, Planning, and Partnerships, National Center for 
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-3423; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Secretary, Department of Health and 
Human Services (HHS), and by delegation the Director, Centers for 
Disease Control and Prevention (CDC), and the Administrator, Health 
Resources and Services Administration (HRSA), are authorized by the 
Public Health Service Act to: (1) conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases and other impairments; (2) assist states and their 
political subdivisions in preventing, suppressing, and treating 
communicable diseases and other preventable conditions and in promoting 
health and well-being; (3) assist public and non-profit private 
entities in preventing, controlling, and treating sexually transmitted 
diseases (STDs), including the human immunodeficiency virus (HIV); (4) 
improve health and achieve health equity through access to quality 
services and a skilled health workforce and innovative programs; (5) 
support healthcare services to persons with or who experience risk for 
HIV, viral hepatitis, and other STDs; (6) advance the education of 
health professionals and the public about HIV, viral hepatitis, and 
other STDs; and (7) adolescent and school health as it pertains to HIV, 
viral hepatitis, and STDs.
    The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHAC) meets at least two times each calendar 
year, or at the discretion of the Designated Federal Officers in 
consultation with the CHAC co-chairs.
    HHS policy stipulates that committee membership be balanced in 
terms of points of view represented and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens and cannot be full-time employees of the 
U.S. Government. Current participation on federal workgroups or prior 
experience serving on a federal advisory committee does not disqualify 
a candidate; however, HHS policy is to avoid excessive individual 
service on advisory committees and multiple committee memberships. The 
CHAC charter stipulates that the Committee must include at least four 
members who are persons with HIV. The Committee may also include 
representation from persons with lived experience, such as those who 
have experienced viral hepatitis, STDs, and drug use; state and local 
health and education agencies; HIV/viral hepatitis/STD community-based 
organizations; and the ethics or faith-based community.
    Committee members are Special Government Employees (SGEs), 
requiring the filing of financial disclosure reports at the beginning 

[[Page 23425]]

and annually during their terms. Individuals who are selected for 
appointment will be required to provide detailed information regarding 
their financial interests and, for example, any work they do for the 
federal government through research grants or contracts. Disclosure of 
this information is required in order for CDC ethics officials to 
determine whether there is a conflict between the SGE's public duties 
as a member of CHAC and the SGE's private interests, including an 
appearance of a loss of impartiality as defined by federal laws and 
regulations, and to identify any required remedial action needed to 
address the potential conflict.
    CDC and HRSA review potential candidates for CHAC membership when a 
vacancy arises and provide a slate of nominees for consideration to the 
Secretary of HHS for final selection. CDC and HRSA each publish a 
Federal Register notice and will be using a joint process to nominate 
nominees on a rolling basis; thus, applications received by CDC will be 
shared with HRSA for consideration. Therefore, potential candidates 
need only apply in response to one of the Federal Register notices. HHS 
notifies selected candidates of their appointment near the start of the 
term in December 2024, or as soon as the HHS selection process is 
completed. Note that the need for different expertise varies from year 
to year and a candidate who is not selected in one year may be 
reconsidered in a subsequent year. Candidates should submit the 
following items:

[ssquf] A letter of interest or personal statement from the nominee 
stating how the nominee's expertise would inform the work of CHAC
[ssquf] A biographical sketch of the nominee (500 words or fewer)
[ssquf] Current curriculum vitae or resume, including complete contact 
information (telephone numbers, mailing address, and email address)
[ssquf] At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (i.e., CDC, National Institutes of 
Health, Food and Drug Administration, etc.).

    Nominations may be submitted directly by the individual seeking 
nomination or by the person/organization recommending the candidate. 
CDC and HRSA will collect and retain nominations received for up to two 
years to create a pool of potential CHAC nominees.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07997 Filed 4-14-23; 8:45 am]